论文部分内容阅读
目的探讨自拟呼吸糖浆Ⅰ号的制备工艺,并观察其治疗急性气管—支气管炎的临床效疗。方法将门诊及住院的急性气管—支气管炎患者251例随机分为观察组139例和对照组112例。观察组给予自拟呼吸糖浆Ⅰ号,每次15～30ml,每天3～4次;对照组给予复方鲜竹沥液,每次20ml,每天2～3次。治疗后比较2组疗效。结果该制剂工艺可行。治疗组总有效率为94.2%高于对照组的87.5%,差异有统计学意义(P<0.05)。结论自拟呼吸糖浆Ⅰ号使用安全方便,疗效确切,值得临床推广应用。
Objective To investigate the preparation technology of self-prepared respiratory syrup Ⅰ and to observe its clinical efficacy in the treatment of acute tracheobronchitis. Methods A total of 251 outpatients and hospitalized patients with acute tracheobronchitis were randomly divided into observation group (139 cases) and control group (112 cases). The observation group given self breathing syrup Ⅰ, each 15 ~ 30ml, 3 to 4 times a day; the control group given compound fresh bamboo leachate, each 20ml, 2 to 3 times a day. After treatment, two groups were compared. The results of the preparation process feasible. The total effective rate in the treatment group was 94.2% higher than 87.5% in the control group, the difference was statistically significant (P <0.05). Conclusion It is safe and convenient to use respiratory syrup Ⅰ and its curative effect is worthy of clinical application.